Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.

Munoz FM, Anderson EJ, Bernstein DI, Harrison CJ, Pahud B, Anderson E, Creech CB, Berry AA, Kotloff KL, Walter EB, Atmar RL, Bellamy AR, Chang S, Keitel WA.

Vaccine. 2019 Aug 23;37(36):5161-5170. doi: 10.1016/j.vaccine.2019.07.085. Epub 2019 Jul 30.

PMID:
31375440
2.

Improving Influenza Prevention: Modest Changes with Large Effects.

Walter EB, Atmar RL.

Clin Infect Dis. 2019 Jul 25. pii: ciz683. doi: 10.1093/cid/ciz683. [Epub ahead of print] No abstract available.

PMID:
31344224
3.

Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges.

Estes MK, Ettayebi K, Tenge VR, Murakami K, Karandikar U, Lin SC, Ayyar BV, Cortes-Penfield NW, Haga K, Neill FH, Opekun AR, Broughman JR, Zeng XL, Blutt SE, Crawford SE, Ramani S, Graham DY, Atmar RL.

Viruses. 2019 Jul 11;11(7). pii: E638. doi: 10.3390/v11070638. Review.

4.

Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.

Keitel WA, Voronca DC, Atmar RL, Paust S, Hill H, Wolff MC, Bellamy AR; VTEU H5N1 Vaccine Working Group.

Vaccine. 2019 May 31. pii: S0264-410X(19)30554-7. doi: 10.1016/j.vaccine.2019.04.066. [Epub ahead of print]

PMID:
31160101
5.

Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017.

Chow NA, Toda M, Pennington AF, Anassi E, Atmar RL, Cox-Ganser JM, Da Silva J, Garcia B, Kontoyiannis DP, Ostrosky-Zeichner L, Leining LM, McCarty J, Al Mohajer M, Murthy BP, Park JH, Schulte J, Shuford JA, Skrobarcek KA, Solomon S, Strysko J, Chiller TM, Jackson BR, Chew GL, Beer KD.

MMWR Morb Mortal Wkly Rep. 2019 May 31;68(21):469-473. doi: 10.15585/mmwr.mm6821a1.

6.

Norovirus in health care and implications for the immunocompromised host.

Chong PP, Atmar RL.

Curr Opin Infect Dis. 2019 Aug;32(4):348-355. doi: 10.1097/QCO.0000000000000557.

PMID:
31107251
7.

Antibody persistence to two Virus-Like Particle norovirus vaccine candidate formulations in healthy adults: one-year follow-up with memory probe vaccination.

Atmar RL, Baehner F, Cramer JP, Lloyd E, Sherwood J, Borkowski A, Mendelman PM; NOR-201 Study Group.

J Infect Dis. 2019 Apr 18. pii: jiz170. doi: 10.1093/infdis/jiz170. [Epub ahead of print]

PMID:
31001633
8.

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

El Sahly HM, Atmar RL, Patel SM, Bellamy A, Liu L, Hong W, Zhu H, Guan Y, Keitel WA; DMID 13-0033 Vaccine Study Group.

Vaccine. 2019 May 1;37(19):2561-2568. doi: 10.1016/j.vaccine.2019.03.071. Epub 2019 Apr 4.

PMID:
30955980
9.

Active Surveillance for Norovirus in a US Veterans Affairs Patient Population, Houston, Texas, 2015-2016.

Kambhampati AK, Vargas B, Mushtaq M, Browne H, Grytdal S, Atmar RL, Vinjé J, Parashar UD, Lopman B, Hall AJ, Rodriguez-Barradas MC, Cardemil CV.

Open Forum Infect Dis. 2019 Mar 6;6(4):ofz115. doi: 10.1093/ofid/ofz115. eCollection 2019 Apr.

10.

Effects of Child and Maternal Histo-Blood Group Antigen Status on Symptomatic and Asymptomatic Enteric Infections in Early Childhood.

Colston JM, Francois R, Pisanic N, Peñataro Yori P, McCormick BJJ, Olortegui MP, Gazi MA, Svensen E, Ahmed MMM, Mduma E, Liu J, Houpt ER, Klapheke R, Schwarz JW, Atmar RL, Black RE, Kosek MN.

J Infect Dis. 2019 Jun 5;220(1):151-162. doi: 10.1093/infdis/jiz072.

11.

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.

El Sahly HM, Gorchakov R, Lai L, Natrajan MS, Patel SM, Atmar RL, Keitel WA, Hoft DF, Barrett J, Bailey J, Edupuganti S, Raabe V, Wu HM, Fairley J, Rouphael N, Murray KO, Mulligan MJ.

Open Forum Infect Dis. 2018 Dec 19;6(1):ofy352. doi: 10.1093/ofid/ofy352. eCollection 2019 Jan.

12.

Influenza Vaccines after Seven Decades: Still on the Learning Curve.

Keitel WA, Atmar RL.

J Infect Dis. 2018 Dec 14. doi: 10.1093/infdis/jiy724. [Epub ahead of print] No abstract available.

PMID:
30561693
13.

An Exploratory Study of the Salivary Immunoglobulin A Responses to 1 Dose of a Norovirus Virus-Like Particle Candidate Vaccine in Healthy Adults.

Atmar RL, Cramer JP, Baehner F, Han C, Borkowski A, Mendelman PM.

J Infect Dis. 2019 Jan 9;219(3):410-414. doi: 10.1093/infdis/jiy529.

PMID:
30203081
14.

Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses.

Alvarado G, Ettayebi K, Atmar RL, Bombardi RG, Kose N, Estes MK, Crowe JE Jr.

Gastroenterology. 2018 Dec;155(6):1898-1907. doi: 10.1053/j.gastro.2018.08.039. Epub 2018 Aug 28.

PMID:
30170116
15.

Human noroviruses: recent advances in a 50-year history.

Atmar RL, Ramani S, Estes MK.

Curr Opin Infect Dis. 2018 Oct;31(5):422-432. doi: 10.1097/QCO.0000000000000476. Review.

PMID:
30102614
16.

Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation.

Costantini V, Morantz EK, Browne H, Ettayebi K, Zeng XL, Atmar RL, Estes MK, Vinjé J.

Emerg Infect Dis. 2018 Aug;24(8):1453-1464. doi: 10.3201/eid2408.180126.

17.

Dialysis Catheter-related Bloodstream Infections in Patients Receiving Hemodialysis on an Emergency-only Basis: A Retrospective Cohort Analysis.

Zhang HH, Cortés-Penfield NW, Mandayam S, Niu J, Atmar RL, Wu E, Chen D, Zamani R, Shah MK.

Clin Infect Dis. 2019 Mar 5;68(6):1011-1016. doi: 10.1093/cid/ciy555.

18.

Glycan recognition in globally dominant human rotaviruses.

Hu L, Sankaran B, Laucirica DR, Patil K, Salmen W, Ferreon ACM, Tsoi PS, Lasanajak Y, Smith DF, Ramani S, Atmar RL, Estes MK, Ferreon JC, Prasad BVV.

Nat Commun. 2018 Jul 6;9(1):2631. doi: 10.1038/s41467-018-05098-4.

19.

Prospects and Challenges in the Development of a Norovirus Vaccine.

Cortes-Penfield NW, Ramani S, Estes MK, Atmar RL.

Clin Ther. 2017 Aug;39(8):1537-1549. doi: 10.1016/j.clinthera.2017.07.002. Epub 2017 Jul 26. Review.

20.

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group.

Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24.

21.

Structural features of glycan recognition among viral pathogens.

Shanker S, Hu L, Ramani S, Atmar RL, Estes MK, Venkataram Prasad BV.

Curr Opin Struct Biol. 2017 Jun;44:211-218. doi: 10.1016/j.sbi.2017.05.007. Epub 2017 Jun 4. Review.

22.

Community Environmental Contamination of Toxigenic Clostridium difficile.

Alam MJ, Walk ST, Endres BT, Basseres E, Khaleduzzaman M, Amadio J, Musick WL, Christensen JL, Kuo J, Atmar RL, Garey KW.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofx018. doi: 10.1093/ofid/ofx018. eCollection 2017 Winter.

23.

Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.

Sharma S, Carlsson B, Czakó R, Vene S, Haglund M, Ludvigsson J, Larson G, Hammarström L, Sosnovtsev SV, Atmar RL, Green KY, Estes MK, Svensson L.

J Virol. 2017 Jun 26;91(14). pii: e00567-17. doi: 10.1128/JVI.00567-17. Print 2017 Jul 15.

24.

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.

Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB.

Vaccine. 2017 Mar 23;35(13):1675-1682. doi: 10.1016/j.vaccine.2017.02.032. Epub 2017 Feb 27.

PMID:
28256358
25.

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.

Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00571-16. doi: 10.1128/CVI.00571-16. Print 2017 May.

26.

Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses.

Hurwitz AM, Huang W, Kou B, Estes MK, Atmar RL, Palzkill T.

PLoS One. 2017 Jan 17;12(1):e0170162. doi: 10.1371/journal.pone.0170162. eCollection 2017.

27.

Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus.

Hurwitz AM, Huang W, Estes MK, Atmar RL, Palzkill T.

Protein Eng Des Sel. 2017 Feb;30(2):129-139. doi: 10.1093/protein/gzw074. Epub 2016 Dec 28.

28.
29.

Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.

Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, Atmar RL, Crowe JE Jr, Estes MK, Prasad BV.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5830-E5837. Epub 2016 Sep 19.

30.

Replication of human noroviruses in stem cell-derived human enteroids.

Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng XL, Qu L, Kou B, Opekun AR, Burrin D, Graham DY, Ramani S, Atmar RL, Estes MK.

Science. 2016 Sep 23;353(6306):1387-1393. Epub 2016 Aug 25.

31.

Correction for Hesse et al., Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection.

Hesse S, Neill FH, Estes MK, Shanker S, Prasad BV, Ferreira J, Atmar RL.

Clin Vaccine Immunol. 2016 Aug 5;23(8):735. doi: 10.1128/CVI.00260-16. Print 2016 Aug. No abstract available.

32.

Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.

Qu L, Murakami K, Broughman JR, Lay MK, Guix S, Tenge VR, Atmar RL, Estes MK.

J Virol. 2016 Sep 12;90(19):8906-23. doi: 10.1128/JVI.01425-16. Print 2016 Oct 1.

33.

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi K, Papanicolaou GA, Jongwutiwes U, Perales MA, Shia J, Mercer D, Finegold MJ, Vinjé J, Atmar RL, Estes MK.

J Gen Virol. 2016 Sep;97(9):2291-300. doi: 10.1099/jgv.0.000545. Epub 2016 Jul 12.

34.

Prevalence of hypervirulent Klebsiella pneumoniae-associated genes rmpA and magA in two tertiary hospitals in Houston, TX, USA.

Chou A, Nuila RE, Franco LM, Stager CE, Atmar RL, Zechiedrich L.

J Med Microbiol. 2016 Sep;65(9):1047-8. doi: 10.1099/jmm.0.000309. Epub 2016 Jul 8. No abstract available.

35.

Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.

Sapparapu G, Czakó R, Alvarado G, Shanker S, Prasad BV, Atmar RL, Estes MK, Crowe JE Jr.

PLoS Pathog. 2016 Jun 29;12(6):e1005719. doi: 10.1371/journal.ppat.1005719. eCollection 2016 Jun.

36.

Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.

Atmar RL, Baehner F, Cramer JP, Song E, Borkowski A, Mendelman PM; NOR-201 Study Group.

J Infect Dis. 2016 Sep 15;214(6):845-53. doi: 10.1093/infdis/jiw259. Epub 2016 Jun 28.

37.

Antiviral targets of human noroviruses.

Prasad BV, Shanker S, Muhaxhiri Z, Deng L, Choi JM, Estes MK, Song Y, Palzkill T, Atmar RL.

Curr Opin Virol. 2016 Jun;18:117-25. doi: 10.1016/j.coviro.2016.06.002. Epub 2016 Jun 17. Review.

38.

Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Ramani S, Estes MK, Atmar RL.

PLoS Pathog. 2016 Apr 26;12(4):e1005334. doi: 10.1371/journal.ppat.1005334. eCollection 2016 Apr. Review. No abstract available.

39.

Flotation Immunoassay: Masking the Signal from Free Reporters in Sandwich Immunoassays.

Chen H, Hagström AE, Kim J, Garvey G, Paterson A, Ruiz-Ruiz F, Raja B, Strych U, Rito-Palomares M, Kourentzi K, Conrad JC, Atmar RL, Willson RC.

Sci Rep. 2016 Apr 14;6:24297. doi: 10.1038/srep24297.

40.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike IN, Atmar RL, Patel SM, Corry DB, Winokur PL, Brady RC, Chen WH, Edwards KM, Creech CB, Walter EB Jr, Frey SE, Belshe RB, Goll JB, Hill H, Keitel WA.

Vaccine. 2016 Jan 20;34(4):547-554. doi: 10.1016/j.vaccine.2015.11.055. Epub 2015 Dec 4.

41.

Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection.

Hesse S, Neill FH, Estes MK, Shanker S, Prasad BV, Ferreira J, Atmar RL.

Clin Vaccine Immunol. 2015 Dec 9;23(2):181-3. doi: 10.1128/CVI.00595-15. Print 2016 Feb. Erratum in: Clin Vaccine Immunol. 2016 Aug;23(8):735.

42.

Shunting in cryptococcal meningitis.

Cherian J, Atmar RL, Gopinath SP.

J Neurosurg. 2016 Jul;125(1):177-86. doi: 10.3171/2015.4.JNS15255. Epub 2015 Oct 30.

PMID:
26517766
43.

Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?

Atmar RL, Keitel WA.

J Infect Dis. 2016 Apr 15;213(8):1211-3. doi: 10.1093/infdis/jiv459. Epub 2015 Oct 28. No abstract available.

PMID:
26516140
44.

Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies.

Kou B, Huang W, Neill FH, Palzkill T, Estes MK, Atmar RL.

J Clin Microbiol. 2015 Dec;53(12):3916-8. doi: 10.1128/JCM.02371-15. Epub 2015 Oct 7.

45.

In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Aitken SL, Alam MJ, Khaleduzzaman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318-23. doi: 10.1017/ice.2015.187. Epub 2015 Aug 20. Erratum in: Infect Control Hosp Epidemiol. 2016 Jan;37(1):124. Khaleduzzuman, Mohammed [corrected to Khaleduzzaman, Mohammed].

46.

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR.

JAMA. 2015 Jul 21;314(3):237-46. doi: 10.1001/jama.2015.7916.

PMID:
26197184
47.

Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections--A Prospective Cohort Study.

Zhai Y, Franco LM, Atmar RL, Quarles JM, Arden N, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, Shaw CA, Belmont JW, Couch RB.

PLoS Pathog. 2015 Jun 12;11(6):e1004869. doi: 10.1371/journal.ppat.1004869. eCollection 2015 Jun.

48.

Serological Correlates of Protection against a GII.4 Norovirus.

Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM.

Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3.

49.

Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay.

Hagström AE, Garvey G, Paterson AS, Dhamane S, Adhikari M, Estes MK, Strych U, Kourentzi K, Atmar RL, Willson RC.

PLoS One. 2015 May 15;10(5):e0126571. doi: 10.1371/journal.pone.0126571. eCollection 2015.

50.

Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

Ye X, Van JN, Munoz FM, Revell PA, Kozinetz CA, Krance RA, Atmar RL, Estes MK, Koo HL.

Am J Transplant. 2015 Jul;15(7):1874-81. doi: 10.1111/ajt.13227. Epub 2015 Mar 18.

Supplemental Content

Loading ...
Support Center